Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Beijing Tinavi Medical Gains China Rights to Spineway's Spinal Devices

publication date: Nov 22, 2016
Beijing Tinavi Medical Technologies in-licensed China rights to spinal implants and surgical devices made by Spineway of Lyon, France. Tinavi made a $1.5 million investment in Spineway for five-year exclusive distribution rights, giving them a 9% stake in Spineway. The shares also have warrants attached that would raise Tinavi's ownership in Spineway to 17% in exchange for an additional $1.7 million. Tinavi markets a robotic surgical device, Phecda™, in China that is used for trauma and spine surgeries. More details....

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital